CAS 113627-25-1
:(2R,3S,11bS)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol
Description:
The chemical substance known as (2R,3S,11bS)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol, with the CAS number 113627-25-1, is a complex organic compound characterized by its multi-ring structure and specific stereochemistry. It features a benzoquinolizin framework, which is a bicyclic structure that incorporates nitrogen and exhibits a variety of functional groups, including methoxy and hydroxyl groups. The presence of isobutyl and methoxy substituents contributes to its unique chemical properties, potentially influencing its solubility, reactivity, and biological activity. The stereochemical configuration, indicated by the (2R,3S,11bS) notation, suggests that the compound has specific three-dimensional orientations that can affect its interaction with biological targets. Such compounds may be of interest in medicinal chemistry for their potential pharmacological effects, although detailed studies would be necessary to elucidate their biological activity and therapeutic applications.
Formula:C19H29NO3
InChI:InChI=1/C19H29NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16-17,21H,5-7,10-11H2,1-4H3/t14-,16-,17+/m0/s1
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 6 products.
cis-Dihydro Tetrabenazine
CAS:Formula:C19H29NO3Color and Shape:White To Off-White SolidMolecular weight:319.45cis (2,3)-Dihydro Tetrabenazine-d6
CAS:Controlled Product<p>Applications A labelled metabolite of Tetrabenazine in vivo, which is likely the active pharmacological agent. The cis izomer of Dihydrotetrabenazine is used for the treatment of hyperkinetic movement disorders.<br>References Kilbourn, M., et al.: Eur. J. Pharmacol., 278, 249 (1995), Perera, R., et al.: J. Med. Chem., 46, 2599 (2003), Mager, D., et al.: J. Pharm. Sci., 94, 2475 (2005), Zheng, G., et al.: Bioorg. Med. Chem., 16, 5018 (2006),<br></p>Formula:C19H23D6NO3Color and Shape:NeatMolecular weight:325.48rac-(2,3)-Dihydro Tetrabenazine-13C2,D6 [Cis/Trans Mixture]
CAS:Controlled ProductFormula:C17C2H23D6NO3Color and Shape:NeatMolecular weight:654.922rac-(2,3)-Dihydro Tetrabenazine [Cis/Trans Mixture]
CAS:Controlled Product<p>Applications rac-(2,3)-Dihydro Tetrabenazine [Cis/Trans Mixture] is a mixture of cis-2,3-Dihydro Tetrabenazine (D449650) and trans-2,3-Dihydro Tetrabenazine (D449655); used in the treatment of hyperkinetic movement disorders.<br>References Kilbourn, M., et al.: Eur. J. Pharmacol., 278, 249 (1995); Perera, R., et al.: J. Med. Chem., 46, 2599 (2003); Mager, D., et al.: J. Pharm. Sci., 94, 2475 (2005); Zheng, G., et al.: Bioorg. Med. Chem., 16, 5018 (2006)<br></p>Formula:C19H29NO3Color and Shape:NeatMolecular weight:638.877cis (2,3)-Dihydro Tetrabenazine
CAS:Controlled Product<p>Applications A metabolite of Tetrabenazine in vivo, which is likely the active pharmacological agent. The cis isomer of Dihydrotetrabenazine is used for the treatment of hyperkinetic movement disorders.<br>References Kilbourn, M., et al.: Eur. J. Pharmacol., 278, 249 (1995), Perera, R., et al.: J. Med. Chem., 46, 2599 (2003), Mager, D., et al.: J. Pharm. Sci., 94, 2475 (2005), Zheng, G., et al.: Bioorg. Med. Chem., 16, 5018 (2006),<br></p>Formula:C19H29NO3Color and Shape:NeatMolecular weight:319.44


